When to Adjust the Protocol Signs It Is Working Improved skin hydration and texture (week 2-4) Faster healing of minor cuts and skin abrasions (week 2-4) Reduced fine line depth visible under angled lighting (week 6-8) Declining hs-CRP on bloodwork (week 4-6) Increasing P1NP (collagen formation marker) on bloodwork (week 4-8) Improved nail quality thickness, growth rate, reduced brittleness (week 4-8) Signs to Reassess No changes to skin texture after 8 weeks of consistent use verify product concentration, purity (COA), and application frequency Elevated serum copper on bloodwork reduce dose or extend off-cycle period Skin irritation at injection site rotate injection sites, check reconstitution technique in our GHK-Cu Reconstitution Guide No measurable P1NP increase after a full 8-week cycle the collagen-stimulating mechanism may not be engaging, possibly due to substrate deficiency (protein, vitamin C) or product quality issues When to Stop Community sources describe discontinuing and consulting a physician on significantly elevated serum copper levels, signs of copper toxicity (nausea, abdominal pain, liver enzyme elevation), or any unexpected systemic reactions
Intraocular pressure was assessed in normal rats, and values between 13 and 19 mmHg were considered normal, in accordance with previous rat data ( To assess the effect of retrobulbar administration itself, the values were assessed before retrobulbar application, after retrobulbar application of saline (0.1 ml/each eye), BPC 157 1 g/0.1 ml saline/each eye, or L-NAME 0.5 mg/0.1 ml saline/each eye, at 1, 2, 4, 6, 8, and 10 min thereafter
In this episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson sits down with Jeff Moshal, CEO of Genus Lifesciences Inc., for an in-depth discussion about the critical state of natural desiccated thyroid (NDT) medications, including their flagship product Ren Thyroid
125):S7384
